Lipella pharmaceuticals co-founder michael chancellor featured on the pharmaverse podcast

Episode titled “from medicine to biotech innovation” now available pittsburgh, march 31, 2025 – prism mediawire – lipella pharmaceuticals inc. (nasdaq: lipo) (“lipella,” “our,” “us,” or the “company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced that co-founder and chief medical officer dr.
LIPO Ratings Summary
LIPO Quant Ranking